1. Home
  2. PRTA vs TGI Comparison

PRTA vs TGI Comparison

Compare PRTA & TGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • TGI
  • Stock Information
  • Founded
  • PRTA 2012
  • TGI 1993
  • Country
  • PRTA Ireland
  • TGI United States
  • Employees
  • PRTA N/A
  • TGI N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • TGI Aerospace
  • Sector
  • PRTA Health Care
  • TGI Industrials
  • Exchange
  • PRTA Nasdaq
  • TGI Nasdaq
  • Market Cap
  • PRTA 1.2B
  • TGI 1.1B
  • IPO Year
  • PRTA N/A
  • TGI 1996
  • Fundamental
  • Price
  • PRTA $21.89
  • TGI $12.97
  • Analyst Decision
  • PRTA Buy
  • TGI Buy
  • Analyst Count
  • PRTA 7
  • TGI 9
  • Target Price
  • PRTA $58.83
  • TGI $16.67
  • AVG Volume (30 Days)
  • PRTA 255.3K
  • TGI 765.0K
  • Earning Date
  • PRTA 10-31-2024
  • TGI 08-07-2024
  • Dividend Yield
  • PRTA N/A
  • TGI N/A
  • EPS Growth
  • PRTA N/A
  • TGI 521.30
  • EPS
  • PRTA N/A
  • TGI 6.72
  • Revenue
  • PRTA $217,246,000.00
  • TGI $1,209,236,000.00
  • Revenue This Year
  • PRTA $59.66
  • TGI $2.85
  • Revenue Next Year
  • PRTA N/A
  • TGI $10.60
  • P/E Ratio
  • PRTA N/A
  • TGI $2.02
  • Revenue Growth
  • PRTA 276.98
  • TGI 15.72
  • 52 Week Low
  • PRTA $18.69
  • TGI $7.00
  • 52 Week High
  • PRTA $55.89
  • TGI $17.87
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.55
  • TGI 45.11
  • Support Level
  • PRTA $20.15
  • TGI $12.52
  • Resistance Level
  • PRTA $22.83
  • TGI $13.84
  • Average True Range (ATR)
  • PRTA 0.82
  • TGI 0.43
  • MACD
  • PRTA 0.13
  • TGI 0.07
  • Stochastic Oscillator
  • PRTA 82.66
  • TGI 54.94

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About TGI Triumph Group Inc.

Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.

Share on Social Networks: